0001562180-17-002413.txt : 20170705
0001562180-17-002413.hdr.sgml : 20170705
20170705174620
ACCESSION NUMBER: 0001562180-17-002413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170701
FILED AS OF DATE: 20170705
DATE AS OF CHANGE: 20170705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eansor Norman David
CENTRAL INDEX KEY: 0001270905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 17948671
MAIL ADDRESS:
STREET 1: 8100 SOUTHPARK WAY, A-8
CITY: LITTLETON
STATE: CO
ZIP: 80120
FORMER NAME:
FORMER CONFORMED NAME: EANSOR N DAVID
DATE OF NAME CHANGE: 20031120
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-07-01
false
0000842023
BIO-TECHNE Corp
TECH
0001270905
Eansor Norman David
8100 SOUTHPARK WAY, A-8
LITTLETON
CO
80120
false
true
false
false
SVP - Novus Biologicals
Common Stock
2017-07-01
4
F
false
534.00
117.50
D
3402.00
D
Restricted Stock Units
Common Stock
1500.00
1500.00
D
Restricted Stock Units
Common Stock
2287.00
2287.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
12500.00
12500.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
9375.00
9375.00
D
Stock Option (Right to Buy)
94.35
2021-08-12
Common Stock
15000.00
15000.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
18819.00
18819.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
14114.00
14114.00
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.
/s/ Kathy Backes as Attorney-in-Fact for David N. Eansor pursuant to Power of Attorney previously filed.
2017-07-05